Baek, D. J., MacRitchie, N., Pyne, N. J., Pyne, S. and Bittman, R. (2013) Synthesis of selective inhibitors of sphingosine kinase 1. Chemical Communications, 49(21), pp. 2136-2138. (doi: 10.1039/C3CC00181D) (PMID:23388656) (PMCID:PMC3608193)
|
Text
123841.pdf - Published Version Available under License Creative Commons Attribution. 1MB |
Abstract
Sphingosine kinase isoform 1 (SK1) inhibitors may serve as therapeutic agents for proliferative diseases, including hypertension. We synthesized a series of sphingosine-based SK1-selective inhibitors, the most potent of which is RB-005 (IC50 = 3.6 μM), which also induced proteasomal degradation of SK1 in human pulmonary arterial smooth muscle cells.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | MacRitchie, Dr Neil |
Authors: | Baek, D. J., MacRitchie, N., Pyne, N. J., Pyne, S., and Bittman, R. |
College/School: | College of Medical Veterinary and Life Sciences > School of Infection & Immunity |
Journal Name: | Chemical Communications |
Publisher: | Royal Society of Chemistry |
ISSN: | 1359-7345 |
ISSN (Online): | 1364-548X |
Published Online: | 28 January 2013 |
Copyright Holders: | Copyright © 2013 The Royal Society of Chemistry |
First Published: | First published in Chemical Communications 49(21): 2136-2138 |
Publisher Policy: | Reproduced under a Creative Commons License |
University Staff: Request a correction | Enlighten Editors: Update this record